|
Showing the most relevant articles for your search:NASDAQ:FLKS Date | Time | Source | Headline | Symbol | Company | 07/01/2019 | 3:02PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/27/2019 | 6:03AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/26/2019 | 9:01AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/25/2019 | 10:06AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/25/2019 | 7:00AM | Business Wire | Flex Pharma Announces Broker Authority to Vote on Certain Proposals | NASDAQ:FLKS | Flex Pharma, Inc. |
06/19/2019 | 10:08AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/17/2019 | 12:47PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/14/2019 | 5:26PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/14/2019 | 5:24PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/10/2019 | 4:17PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/10/2019 | 10:21AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
06/06/2019 | 10:01AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/31/2019 | 7:01AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/28/2019 | 10:32AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/22/2019 | 3:13PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/20/2019 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/17/2019 | 9:54AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/16/2019 | 10:40AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/10/2019 | 5:31PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/10/2019 | 5:30PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/01/2019 | 4:18PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/01/2019 | 7:33AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
05/01/2019 | 7:00AM | Business Wire | Flex Pharma Reports First Quarter 2019 Financial Results | NASDAQ:FLKS | Flex Pharma, Inc. |
04/30/2019 | 6:12AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:FLKS | Flex Pharma, Inc. |
04/29/2019 | 3:23PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:FLKS | Flex Pharma, Inc. |
04/24/2019 | 4:16PM | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:FLKS | Flex Pharma, Inc. |
04/18/2019 | 6:01AM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
04/16/2019 | 4:13PM | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
03/26/2019 | 6:06AM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
03/06/2019 | 5:09PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:FLKS | Flex Pharma, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:FLKS |
|